Immune signaling in IBD triggers tumor-promoting neutrophils which is linked to an increased risk of colorectal cancer.
The U.S. Food and Drug Administration (FDA) has approved Guardant360 CDx as a companion diagnostic to identify patients with ...
Biomarker testing is changing how colorectal cancer is treated, giving patients more personalized and effective care. By ...
A mom recalls her first symptoms of colorectal cancer, which she mistook for hemorrhoids caused by her pregnancy at the time.
I get nervous seeing the headlines about the rise in colorectal cancer cases. What can I do right now to lower my risk?